Works matching DE "EXEMESTANE"

Results: 89
    1
    2
    3
    4

    Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.

    Published in:
    Molecular & Clinical Oncology, 2018, v. 9, n. 3, p. 255, doi. 10.3892/mco.2018.1672
    By:
    • Riccardi, Ferdinando;
    • Colantuoni, Giuseppe;
    • Diana, Anna;
    • Mocerino, Carmela;
    • Cartenì, Giacomo;
    • Lauria, Rossella;
    • Febbraro, Antonio;
    • Nuzzo, Francesco;
    • Addeo, Raffaele;
    • Marano, Ombretta;
    • Incoronato, Pasquale;
    • De Placido, Sabino;
    • Ciardiello, Fortunato;
    • Orditura, Michele
    Publication type:
    Article
    5
    6
    7
    8

    Paget's Disease of the Male Breast.

    Published in:
    International Journal of Gerontology, 2022, v. 16, n. 4, p. 407, doi. 10.6890/IJGE.202210_16(4).0020
    By:
    • Shih-Ting Chen;
    • Chien-Ming Chao;
    • Wei-Ting Lin
    Publication type:
    Article
    9
    10
    11

    Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-239
    By:
    • Yutaka Yamamoto;
    • Takashi Ishikawa;
    • Yasuo Hozumi;
    • Masahiko Ikeda;
    • Hiroji Iwata;
    • Hiroko Yamashita;
    • Tatsuya Toyama;
    • Takashi Chishima;
    • Shigehira Saji;
    • Mutsuko Yamamoto-Ibusuki;
    • Hirotaka Iwase
    Publication type:
    Article
    12
    13
    14
    15
    16

    Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis.

    Published in:
    Acta Oncologica, 2015, v. 54, n. 3, p. 349, doi. 10.3109/0284186X.2014.964809
    By:
    • van Nes, Johanna G. H.;
    • Beex, Louk V. A. M.;
    • Seynaeve, Caroline;
    • Putter, Hein;
    • Sramek, Alexandr;
    • Lardenoije, Susanne;
    • Duijm-de Carpentier, Marjolijn;
    • Rongen, Inge Van;
    • Nortier, Johan W. R.;
    • Zonderland, Harmien M.;
    • van de Velde, Cornelis J. H.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Cancer Diagnostic and Predictive Biomarkers 2018.

    Published in:
    BioMed Research International, 2019, p. 1, doi. 10.1155/2019/3879015
    By:
    • Buonaguro, Franco M.;
    • Caposio, Patrizia;
    • Tornesello, Maria Lina;
    • De Re, Valli;
    • Franco, Renato
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.

    Published in:
    Oncology Research & Treatment, 2018, v. 41, n. 3, p. 93, doi. 10.1159/000485566
    By:
    • Schochter, Fabienne;
    • Rack, Brigitte;
    • Tzschaschel, Marie;
    • Polasik, Arkadius;
    • Andergassen, Ulrich;
    • Trapp, Elisabeth;
    • Alunni-Fabbroni, Marianna;
    • Schneeweiss, Andreas;
    • Müller, Volkmar;
    • Pantel, Klaus;
    • Gade, Jörg;
    • Lorenz, Ralf;
    • Rezai, Mahdi;
    • Tesch, Hans;
    • Soeling, Ulrike;
    • Fehm, Tanja;
    • Mahner, Sven;
    • Schindlbeck, Christian;
    • Lichtenegger, Werner;
    • Beckmann, Matthias W.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.

    Published in:
    Breast Journal, 2019, v. 25, n. 6, p. 1310, doi. 10.1111/tbj.13474
    By:
    • Conforti, Alessandro;
    • Schettini, Francesco;
    • Vallone, Roberta;
    • Di Rella, Francesca;
    • De Rosa, Pasquale;
    • De Santo, Irene;
    • Giuliano, Mario;
    • Arpino, Grazia;
    • Lauria, Rossella;
    • De Placido, Sabino;
    • Caputo, Roberta;
    • De Laurentiis, Michelino;
    • Nazzaro, Giovanni;
    • De Placido, Giuseppe;
    • Locci, Mariavittoria;
    • Alviggi, Carlo
    Publication type:
    Article
    42
    43
    44
    45
    46

    Early Changes of the Standardized Uptake Values (SUV max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3314, doi. 10.3390/cancers12113314
    By:
    • Sirico, Marianna;
    • Bernocchi, Ottavia;
    • Sobhani, Navid;
    • Giudici, Fabiola;
    • Corona, Silvia P.;
    • Vernieri, Claudio;
    • Nichetti, Federico;
    • Cappelletti, Maria Rosa;
    • Milani, Manuela;
    • Strina, Carla;
    • Cervoni, Valeria;
    • Barbieri, Giuseppina;
    • Ziglioli, Nicoletta;
    • Dester, Martina;
    • Bianchi, Giulia Valeria;
    • De Braud, Filippo;
    • Generali, Daniele
    Publication type:
    Article
    47

    Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10).

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3265, doi. 10.3390/cancers12113265
    By:
    • Lee, Soohyeon;
    • Im, Seock-Ah;
    • Kim, Gun Min;
    • Jung, Kyung Hae;
    • Kang, Seok Yun;
    • Park, In Hae;
    • Kim, Jee Hyun;
    • Lee, Kyoung Eun;
    • Ahn, Hee Kyung;
    • Lee, Moon Hee;
    • Kim, Hee-Jun;
    • Kim, Han Jo;
    • Lee, Jong In;
    • Koh, Su-Jin;
    • Park, Yeon Hee
    Publication type:
    Article
    48
    49
    50